Dead on Lauren , I figure if the share price gets near $2, I'll sell. Even $2 could be 2 or 3 years hence if it ever happens.
Econiche does seem to now be a $25M albatross.
So, if econiche is a non-starter, we have a $55m dept plus 2%of any income and 15% interest on the $20m.
Endo own Urocidin and can dictate pretty well every relavent aspect, including its market timing.
I believe the animal health business will not sustain the company, and BNC will either be bought at $.05 on the dollar, or will declare bankruptcy by 2015.
The above is assuming no startling revelations, which with this company are few and far between.